Cell-based assays are required at various stages of drug development to understand the drug’s mode of action (MoA), to measure potency for lot release, and for the detection of neutralizing antibodies during non-clinical and clinical studies.

Our extensive expertise in cell culture techniques and knowledge of regulatory expectation, as well as our use of the DOE-approach to method optimization, can enable the rapid development of your assay on time and on budget. Our scientists have experience developing and validating cell-based assays with diverse endpoints such as proliferation, toxicity, transfection, cell surface markers, cytokine, and gene expression.